Kodiak Sciences completes enrollment in GLOW2 Phase 3 trial
Kodiak Sciences (KOD) announced that it has completed enrollment in its GLOW2 Phase 3 clinical trial of tarcocimab tedromer in patients with ...
Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in ...
Kodiak Sciences Inc. (Nasdaq: KOD), today announced that it has completed enrollment in its GLOW2 Phase 3 clinical trial of tarcocimab tedromer in patients with diabetic retinopathy ("DR").
Diabetic patients must undergo eye screening regularly
Usha (name changed), 62, was experiencing sudden and painless loss of vision in the right eye for one day when she turned up ...
Diabetes Management: Why Is Regular Eye Screening Important If You Have High Blood Sugar ...
Diabetes can affect many parts of the body, including the eyes. Routine eye exams can help identify the early stages of eye ...